Ulcerative colitis Trials in Białystok, Poland
Conditions / Ulcerative colitis / Białystok, Poland
Research into Ulcerative colitis spans multiple therapeutic approaches and trial phases.
28 total trials for this combination
Showing top 10 of 28 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT03290781 | An Efficacy and Safety Study of Ontamalimab as Maintenance Therapy in Participants With Moderate to Severe Ulcerative Colitis | COMPLETED | PHASE3 |
| NCT03996369 | Etrasimod Versus Placebo as Induction Therapy in Moderately to Severely Active Ulcerative Colitis | COMPLETED | PHASE3 |
| NCT03283085 | A Safety Extension Study of Ontamalimab in Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA) | COMPLETED | PHASE3 |
| NCT03950232 | An Extension Study for Treatment of Moderately to Severely Active Ulcerative Colitis | ACTIVE_NOT_RECRUITING | — |
| NCT04033445 | A Study of Guselkumab in Participants With Moderately to Severely Active Ulcerative Colitis | ACTIVE_NOT_RECRUITING | PHASE2/PHASE3 |
| NCT05535946 | ABTECT - Maintenance | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT02914535 | Filgotinib in Long-Term Extension Study of Adults With Ulcerative Colitis | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT02914522 | Study to Evaluate the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Ulcerative Colitis | COMPLETED | PHASE3 |
| NCT03950232 | An Extension Study for Treatment of Moderately to Severely Active Ulcerative Colitis | ACTIVE_NOT_RECRUITING | — |
| NCT03950232 | An Extension Study for Treatment of Moderately to Severely Active Ulcerative Colitis | ACTIVE_NOT_RECRUITING | — |